Cargando…
Duration of anti-tuberculous therapy in children with persistent tuberculomas
The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329029/ https://www.ncbi.nlm.nih.gov/pubmed/30671250 http://dx.doi.org/10.1177/2050313X18823092 |
_version_ | 1783386753101463552 |
---|---|
author | Shah, Ira Shetty, Naman S |
author_facet | Shah, Ira Shetty, Naman S |
author_sort | Shah, Ira |
collection | PubMed |
description | The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of six cases of children with central nervous system tuberculosis who received anti-tuberculous therapy for a period varying between 23 and 32 months depending on the resolution of lesion seen in neuroradiological scans of the patients. Decrease in number and size of granuloma were noted in all patients while one patient showed complete resolution. After stopping anti-tuberculous therapy, the size of the granuloma remained the same, while in one patient an increase was noted. Thus, the duration of anti-tuberculous therapy in patients with tuberculoma may vary and may be required for longer time based on treatment response. |
format | Online Article Text |
id | pubmed-6329029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-63290292019-01-22 Duration of anti-tuberculous therapy in children with persistent tuberculomas Shah, Ira Shetty, Naman S SAGE Open Med Case Rep Case Report The usual treatment duration of tuberculomas recommended is 1 year. While anti-tuberculous therapy is of absolute necessity for the treatment of central nervous system tuberculosis, no clear guidelines exist regarding the duration of therapy in case of persistent tuberculomas. We present a series of six cases of children with central nervous system tuberculosis who received anti-tuberculous therapy for a period varying between 23 and 32 months depending on the resolution of lesion seen in neuroradiological scans of the patients. Decrease in number and size of granuloma were noted in all patients while one patient showed complete resolution. After stopping anti-tuberculous therapy, the size of the granuloma remained the same, while in one patient an increase was noted. Thus, the duration of anti-tuberculous therapy in patients with tuberculoma may vary and may be required for longer time based on treatment response. SAGE Publications 2019-01-09 /pmc/articles/PMC6329029/ /pubmed/30671250 http://dx.doi.org/10.1177/2050313X18823092 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Shah, Ira Shetty, Naman S Duration of anti-tuberculous therapy in children with persistent tuberculomas |
title | Duration of anti-tuberculous therapy in children with persistent tuberculomas |
title_full | Duration of anti-tuberculous therapy in children with persistent tuberculomas |
title_fullStr | Duration of anti-tuberculous therapy in children with persistent tuberculomas |
title_full_unstemmed | Duration of anti-tuberculous therapy in children with persistent tuberculomas |
title_short | Duration of anti-tuberculous therapy in children with persistent tuberculomas |
title_sort | duration of anti-tuberculous therapy in children with persistent tuberculomas |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329029/ https://www.ncbi.nlm.nih.gov/pubmed/30671250 http://dx.doi.org/10.1177/2050313X18823092 |
work_keys_str_mv | AT shahira durationofantituberculoustherapyinchildrenwithpersistenttuberculomas AT shettynamans durationofantituberculoustherapyinchildrenwithpersistenttuberculomas |